The proposed legislation aims to establish a framework for wholesale distributors of controlled substances and legend drugs to ensure that licensed professionals receive adequate education, communication, and procedural due process before any limitations or terminations of sales occur. The bill emphasizes the importance of clarity in the processes that pharmaceutical wholesalers must follow, particularly in light of federal regulations that took effect on July 1, 2022. It mandates that distributors provide timely information and opportunities for licensed professionals to address concerns related to the distribution of controlled substances, including a complaint-driven process to ensure compliance with state law.

Key provisions of the bill include requirements for wholesale distributors to notify customers of potential violations, conduct interviews and onsite inspections, and provide a minimum notice period before limiting or terminating sales. Additionally, the legislation stipulates that any actions taken by distributors must involve the Arkansas State Board of Pharmacy, which will oversee compliance and may impose penalties for violations. The bill also declares an emergency, highlighting the critical nature of controlled substance distribution for public health and safety, and it is set to take effect immediately upon approval by the Governor.

Statutes affected:
SB 502: 20-64-506